Clinical Trial Update: Levofloxacin Compared With Cefepime in Treating Cancer Patients With Fever and Neutropenia [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing levofloxacin with cefepime in cancer patients with fever and neutropenia; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Febrile Neutropenia
• Leukemia
• Lymphoma
• Solid Tumors

Drugs mentioned

• Cefepime (cefepime)
• Levofloxacin (Levofloxacin)

Snippet

Sponsor: Jonsson Comprehensive Cancer Center | Conditions: Fever, Sweats, and Hot Flashes, Infection | Phase 3 | Status: UNKNOWN